Engineering small-molecule analogues of altiratinib via CREB-regulated transcription co-activator 3-target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases.

Lee, Jeong Hyeon; An, Hongchan; Kwon, HyeJi; Lee, Su-Jeong; Park, Young Hye; Hwang, Ji Sun; Kim, Min Young; Hwang, Hayoung; Kim, Jeong Yoon; Lee, Seung Jin; Chang, Sung Eun; Song, Youngsup

Lee, Jeong Hyeon; An, Hongchan; Kwon, HyeJi; Lee, Su-Jeong; Park, Young Hye; Hwang, Ji Sun; Kim, Min Young; Hwang, Hayoung; Kim, Jeong Yoon; Lee, Seung Jin; Chang, Sung Eun; Song, Youngsup.

Afiliación

Lee JH; Department of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
An H; College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Pocheon, South Korea.
Kwon H; New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Lee SJ; Department of Brain Science, Brain Korea 21 project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Park YH; New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Hwang JS; New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Kim MY; New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Hwang H; New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Kim JY; New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Lee SJ; Department of Brain Science, Brain Korea 21 project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Chang SE; Department of Brain Science, Brain Korea 21 project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Song Y; Department of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.

Clin Transl Med ; 14(3): e1625, 2024 03.

Article en En | MEDLINE | ID: mdl-38481372

Asunto(s)

Inhibidores de la Angiogénesis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis Idioma: En Revista: Clin Transl Med Año: 2024 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google